Pharmacological targeting of anatomical structures in the indirect basal ganglia circuit as symptomatic and neuroprotective approaches for Parkinson's Disease

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/201030/09/2014

Collaborative partners

Funding

  • Eli Lilly & Co Ltd: £29,400.00